Paper
Organic & Biomolecular Chemistry
1
solid; mp 86–87 °C; H NMR (400 MHz, CDCl3) δ 7.66 (1H, s), 13.5 Hz, SCH2Ar), 4.37 (1H, brs, H-3′), 3.86 (3H, s, Ar-OCH3),
6.86 (1H, s, H-2 or H-5), 4.03 (2H, d, J = 8.5 Hz, SCH2Ar), 3.99 3.85 (3H, s, Ar-OCH3), 3.81–3.77 (1H, m, H-4′), 3.60–3.57 (1H,
(3H, s, Ar-OCH3), 3.95 (3H, s, Ar-OCH3), 2.23 (1H, t, J = 8.5 Hz, m, H-5′a), 3.46–3.44 (1H, m, H-5′b), 2.98–2.91 (1H, m, H-2′a),
SH); 13C NMR (100 MHz, CDCl3) δ 153.3, 147.8, 139.6, 132.0, 2.12–2.06 (1H, m, H-2′b); 13C NMR (100 MHz, DMSO-d6)
112.5, 108.2, 56.3, 56.2, 27.0; IR (KBr) 2577, 1520, 1273 cm−1
FAB-LRMS m/z
C9H11NNaO4S 252.0306, found 252.0306.
6-N-Benzoyl-5′-O-(4,4′-dimethoxytrityl)-8-(6-nitroveratrylthio)- (MH+); FAB-HRMS calcd for C19H22N5O8S 480.1189, found
2′-deoxyadenosine (4). To
solution of 318 (300 mg, 480.1207.
0.408 mmol) in dry DMF (4.10 mL) were added K2CO3 5′-O-(4,4′-Dimethoxytrityl)-8-(6-nitroveratrylthio)-2′-deoxyino-
;
δ 155.6, 152.6, 149.5, 147.9, 146.5, 145.2, 139.7, 127.4, 124.7,
252 (MNa+); FAB-HRMS calcd for 115.3, 108.3, 88.0, 84.3, 70.9, 61.9, 56.1, 56.1, 37.2, 34.1; IR
(KBr) 3366, 1686, 1523, 1275 cm−1; FAB-LRMS m/z = 480
=
a
(169 mg, 1.22 mmol) and 2 (103 mg, 0.449 mmol) at room sine (8). To a solution of 7 (560 mg, 1.17 mmol) in dry pyri-
temperature. After being stirred for 1 h at room temperature, dine (12.0 mL) was added 4,4′-dimethoxytrityl chloride
the resulting mixture was partitioned between Et2O and H2O. (474 mg, 1.40 mmol) at room temperature. After being stirred
The separated organic layer was washed with brine, dried for 5 h at room temperature, the reaction was quenched by
(Na2SO4) and concentrated in vacuo. The resulting residue was addition of MeOH. The resulting mixture was partitioned
purified on a silica gel column eluted with hexane–AcOEt (2 : 3 between AcOEt and H2O. The separated organic layer was
to 1 : 2 with 0.5% Et3N) to give 4 (187 mg, 52%) as a yellow washed with saturated aqueous NaHCO3, followed by brine,
foam; 1H NMR (400 MHz, CDCl3) δ 8.93 (1H, brs, NH), 8.43 and then dried (Na2SO4) and concentrated in vacuo. The
(1H, s, H-2), 8.04 (2H, d, J = 7.5 Hz), 7.64–7.16 (14H, m), residue was purified on a silica gel column eluted with CHCl3–
6.77–6.73 (4H, m), 6.27 (1H, t, J = 7.0 Hz, H-1′), 4.99–4.85 (3H, MeOH (50 : 1 with 0.5% Et3N) to give 8 (770 mg, 85%) as a
m, H-3′ and SCH2Ar), 4.06 (1H, dd, J = 10.0 and 6.0 Hz, H-4′), yellow foam; 1H NMR (400 MHz, CDCl3) δ 7.70 (1H, s), 7.67
3.88 (3H, s, Ar-OCH3), 3.76 (3H, s, Ar-OCH3), 3.75 (3H, s, Ar- (1H, s), 7.53 (1H, s), 7.39 (1H, d, J = 7.5 Hz), 7.29–7.18 (1H, m),
OCH3), 3.71 (3H, s, Ar-OCH3), 3.40–3.34 (3H, m, H-2′a and 6.78 (4H, dd, J = 8.5 and 3.0 Hz), 6.20 (1H, t, J = 6.5 Hz, H-1′),
H-5′), 2.38 (1H, brs, OH), 2.33–2.26 (1H, m, H-2′b); 13C NMR 4.95 and 4.91 (each 1H, each d, J = 13.5 Hz, SCH2Ar), 4.76–4.74
(100 MHz, CDCl3) δ 164.7, 158.4, 158.4, 154.1, 153.2, 150.7, (1H, m, H-3′), 4.02–3.99 (1H, m, H-4′), 3.97 (3H, s, Ar-OCH3),
148.4, 146.5, 144.7, 140.8, 135.9, 135.8, 133.8, 132.8, 130.0, 3.92 (3H, s, Ar-OCH3), 3.77 (6H, s, 2 × Ar-OCH3), 3.45–3.42 (1H,
130.0, 128.9, 128.1, 128.0, 127.9, 127.8, 126.8, 123.7, 114.1, m, H-5′a), 3.35–3.31 (1H, m, H-5′b), 3.18–3.11 (1H, m, H-2′a),
113.0, 113.0, 108.0, 86.3, 85.7, 84.3, 72.8, 63.6, 56.4, 56.3, 55.2, 2.30–2.23 (1H, m, H-2′b); 13C NMR (100 MHz, CDCl3) δ 158.4,
37.1, 33.6; IR (KBr) 1721 (CvO), 1521 (NO2 as), 1274 (NO2 sy) 158.0, 153.1, 150.6, 150.0, 148.3, 144.6, 142.7, 139.9, 135.9,
cm−1; [α]D22–64.8 (c 1.00, CHCl3); FAB-LRMS m/z = 885 (MH+); 130.0, 130.0, 128.2, 128.1, 127.7, 126.8, 124.9, 115.0, 113.0,
FAB-HRMS calcd for C47H45N6O10S 885.2918, found 885.2928.
108.2, 86.3, 85.5, 84.2, 72.7, 63.8, 56.6, 56.3, 55.2, 37.5, 34.1; IR
6-N-Benzoyl-5′-O-(4,4′-dimethoxytrityl)-3′-O-(N,N-diisopropyl- (KBr) 3007, 1678, 1519, 1276 cm−1; FAB-LRMS m/z = 782
β-cyanoethylphosphoramidyl)-8-(6-nitroveratrylthio)-2′-deoxy- (MH+); FAB-HRMS calcd for C40H40N5O10S 782.2496, found
adenosine (5). To a suspension of 4 (150 mg, 0.17 mmol) in 782.2531.
dry MeCN (1.7 mL) were added N,N-diisopropylethylamine
5′-O-(4,4′-Dimethoxytrityl)-3′-O-(N,N-diisopropyl-β-cyanoethyl-
(0.089 mL, 0.51 mmol) and 2-cyanoethyl-N,N′-diisopropylchloro- phosphoramidyl)-8-(6-nitroveratrylthio)-2′-deoxyinosine (9). To
phosphoramidite (0.057 mL, 0.26 mmol) at room tempera- a solution of 8 (690 mg, 0.88 mmol) in dry MeCN (8.8 mL) was
ture. After being stirred for 30 min, the resulting mixture was added N,N-diisopropylethylamine (0.46 mL, 2.7 mmol) and
partitioned between AcOEt and H2O. The separated organic 2-cyanoethyl-N,N′-diisopropylchlorophosphoramidite (0.29 mL,
layer was washed with saturated aqueous NaHCO3, followed by 1.3 mmol) at room temperature. After being stirred for 30 min
brine, then dried (Na2SO4) and concentrated in vacuo. The at room temperature, the resulting mixture was partitioned
residue was purified on a silica gel column eluted with hexane– between AcOEt and H2O. The separated organic layer was
AcOEt (3 : 2 with 0.5% Et3N) to give 5 (142 mg, 77%) as a yellow washed with saturated aqueous NaHCO3, followed by brine,
foam; 31P NMR δ 141.4, 141.1; FAB-LRMS m/z = 1085 (MH+); then dried (Na2SO4) and concentrated in vacuo. The residue
FAB-HRMS calcd for C56H62N8O11PS 1085.3996, found was purified on a silica gel column eluted with hexane–AcOEt
1085.4053.
(1 : 4 with 0.5% Et3N) to AcOEt : MeOH (10 : 1 with 0.5% Et3N)
8-(6-Nitroveratrylthio)-2′-deoxyinosine (7). To a solution of to give 9 (600 mg, 74%) as a yellow foam; 31P NMR δ 148.6,
619 (1.65 g, 5.00 mmol) in dry DMF (50.0 mL) were added 148.4; FAB-LRMS m/z = 982 (MH+); FAB-HRMS calcd for
K2CO3 (829 mg, 6.00 mmol) and 2 (1.37 g, 6.00 mmol) at room C49H57N7O11PS 982.3574, found 982.3625.
temperature. After being stirred for 24 h at room temperature,
Oligonucleotide synthesis
the solvent was removed in vacuo. The residue was purified on
a silica gel column eluted with AcOEt to AcOEt–MeOH (10 : 1) Solid-phase oligonucleotide synthesis was performed on an
to give 7 (596 mg, 25%) as a yellow powder; 1H NMR nS-8 Oligonucleotides Synthesizer (GeneDesign, Inc.) using
(400 MHz, DMSO-d6) δ 12.5 (1H, brs, NH), 8.02 (1H, s), 7.68 commercially available reagents and phosphoramidites. The
(1H, s), 7.47 (1H, s), 6.14 (1H, t, J = 6.5 Hz, H-1′), 5.33 (1H, brs, modified phosphoramidite was incorporated into the oligo-
OH), 4.91 (1H, brs, OH), 4.79 and 4.75 (each 1H, each d, J = nucleotide with a coupling efficiency comparable to that
2472 | Org. Biomol. Chem., 2014, 12, 2468–2473
This journal is © The Royal Society of Chemistry 2014